The global Somatostatin for Injection market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
Somatostatin for injection is a synthetic cyclic fourteen amino acid, which is exactly the same as natural growth hormone in chemical structure and action. By intravenous injection, somatostatin inhibits the secretion of growth hormone, thyroid-stimulating hormone, insulin, and glucagon, and suppresses the secretion of gastric acid. It also affects absorption, motility, splanchnic blood flow, and nutritional function of the gastrointestinal tract.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
1mg/Vial segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Somatostatin for Injection include Biocon, Ferring Pharmaceuticals, Serum Institute of India, UCB India Private Limited, Eumedica, Merck, Sanofi, PolyPeptide Group, Samarth Life Sciences Pvt, Hybio Pharmaceutical, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Somatostatin for Injection manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Somatostatin for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Somatostatin for Injection. This report contains market size and forecasts of Somatostatin for Injection in global, including the following market information:
Global Somatostatin for Injection market revenue, 2020-2025, 2026-2032, ($ millions)
Global Somatostatin for Injection market sales, 2020-2025, 2026-2032, (K Units)
Global top five Somatostatin for Injection companies in 2024 (%)
Total Market by Segment:
Global Somatostatin for Injection market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Somatostatin for Injection market segment percentages, by Type, 2024 (%)
1mg/Vial
3mg/Vial
Others
Global Somatostatin for Injection market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Units)
Global Somatostatin for Injection market segment percentages, by Application, 2024 (%)
Hospital
Clinic
Global Somatostatin for Injection market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Units)
Global Somatostatin for Injection market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Somatostatin for Injection revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Somatostatin for Injection revenues share in global market, 2024 (%)
Key companies Somatostatin for Injection sales in global market, 2020-2025 (estimated), (K Units)
Key companies Somatostatin for Injection sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biocon
Ferring Pharmaceuticals
Serum Institute of India
UCB India Private Limited
Eumedica
Merck
Sanofi
PolyPeptide Group
Samarth Life Sciences Pvt
Hybio Pharmaceutical
Yangtze River Pharmaceutical
Hainan Shuangcheng Pharmaceuticals
Hainan Zhonghe Pharmaceutical
Wuhan Hualong
Qingdao Guoda
Chengdu Shengnuo
Kumming Longjin Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Somatostatin for Injection, market overview.
Chapter 2: Global Somatostatin for Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Somatostatin for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Somatostatin for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Somatostatin for Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Somatostatin for Injection Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Somatostatin for Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Somatostatin for Injection Overall Market Size
2.1 Global Somatostatin for Injection Market Size: 2024 VS 2032
2.2 Global Somatostatin for Injection Market Size, Prospects & Forecasts: 2020-2032
2.3 Global Somatostatin for Injection Sales: 2020-2032
3 Company Landscape
3.1 Top Somatostatin for Injection Players in Global Market
3.2 Top Global Somatostatin for Injection Companies Ranked by Revenue
3.3 Global Somatostatin for Injection Revenue by Companies
3.4 Global Somatostatin for Injection Sales by Companies
3.5 Global Somatostatin for Injection Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Somatostatin for Injection Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Somatostatin for Injection Product Type
3.8 Tier 1, Tier 2, and Tier 3 Somatostatin for Injection Players in Global Market
3.8.1 List of Global Tier 1 Somatostatin for Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Somatostatin for Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Somatostatin for Injection Market Size Markets, 2024 & 2032
4.1.2 1mg/Vial
4.1.3 3mg/Vial
4.1.4 Others
4.2 Segment by Type - Global Somatostatin for Injection Revenue & Forecasts
4.2.1 Segment by Type - Global Somatostatin for Injection Revenue, 2020-2025
4.2.2 Segment by Type - Global Somatostatin for Injection Revenue, 2026-2032
4.2.3 Segment by Type - Global Somatostatin for Injection Revenue Market Share, 2020-2032
4.3 Segment by Type - Global Somatostatin for Injection Sales & Forecasts
4.3.1 Segment by Type - Global Somatostatin for Injection Sales, 2020-2025
4.3.2 Segment by Type - Global Somatostatin for Injection Sales, 2026-2032
4.3.3 Segment by Type - Global Somatostatin for Injection Sales Market Share, 2020-2032
4.4 Segment by Type - Global Somatostatin for Injection Price (Manufacturers Selling Prices), 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Somatostatin for Injection Market Size, 2024 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.2 Segment by Application - Global Somatostatin for Injection Revenue & Forecasts
5.2.1 Segment by Application - Global Somatostatin for Injection Revenue, 2020-2025
5.2.2 Segment by Application - Global Somatostatin for Injection Revenue, 2026-2032
5.2.3 Segment by Application - Global Somatostatin for Injection Revenue Market Share, 2020-2032
5.3 Segment by Application - Global Somatostatin for Injection Sales & Forecasts
5.3.1 Segment by Application - Global Somatostatin for Injection Sales, 2020-2025
5.3.2 Segment by Application - Global Somatostatin for Injection Sales, 2026-2032
5.3.3 Segment by Application - Global Somatostatin for Injection Sales Market Share, 2020-2032
5.4 Segment by Application - Global Somatostatin for Injection Price (Manufacturers Selling Prices), 2020-2032
6 Sights by Region
6.1 By Region - Global Somatostatin for Injection Market Size, 2024 & 2032
6.2 By Region - Global Somatostatin for Injection Revenue & Forecasts
6.2.1 By Region - Global Somatostatin for Injection Revenue, 2020-2025
6.2.2 By Region - Global Somatostatin for Injection Revenue, 2026-2032
6.2.3 By Region - Global Somatostatin for Injection Revenue Market Share, 2020-2032
6.3 By Region - Global Somatostatin for Injection Sales & Forecasts
6.3.1 By Region - Global Somatostatin for Injection Sales, 2020-2025
6.3.2 By Region - Global Somatostatin for Injection Sales, 2026-2032
6.3.3 By Region - Global Somatostatin for Injection Sales Market Share, 2020-2032
6.4 North America
6.4.1 By Country - North America Somatostatin for Injection Revenue, 2020-2032
6.4.2 By Country - North America Somatostatin for Injection Sales, 2020-2032
6.4.3 United States Somatostatin for Injection Market Size, 2020-2032
6.4.4 Canada Somatostatin for Injection Market Size, 2020-2032
6.4.5 Mexico Somatostatin for Injection Market Size, 2020-2032
6.5 Europe
6.5.1 By Country - Europe Somatostatin for Injection Revenue, 2020-2032
6.5.2 By Country - Europe Somatostatin for Injection Sales, 2020-2032
6.5.3 Germany Somatostatin for Injection Market Size, 2020-2032
6.5.4 France Somatostatin for Injection Market Size, 2020-2032
6.5.5 U.K. Somatostatin for Injection Market Size, 2020-2032
6.5.6 Italy Somatostatin for Injection Market Size, 2020-2032
6.5.7 Russia Somatostatin for Injection Market Size, 2020-2032
6.5.8 Nordic Countries Somatostatin for Injection Market Size, 2020-2032
6.5.9 Benelux Somatostatin for Injection Market Size, 2020-2032
6.6 Asia
6.6.1 By Region - Asia Somatostatin for Injection Revenue, 2020-2032
6.6.2 By Region - Asia Somatostatin for Injection Sales, 2020-2032
6.6.3 China Somatostatin for Injection Market Size, 2020-2032
6.6.4 Japan Somatostatin for Injection Market Size, 2020-2032
6.6.5 South Korea Somatostatin for Injection Market Size, 2020-2032
6.6.6 Southeast Asia Somatostatin for Injection Market Size, 2020-2032
6.6.7 India Somatostatin for Injection Market Size, 2020-2032
6.7 South America
6.7.1 By Country - South America Somatostatin for Injection Revenue, 2020-2032
6.7.2 By Country - South America Somatostatin for Injection Sales, 2020-2032
6.7.3 Brazil Somatostatin for Injection Market Size, 2020-2032
6.7.4 Argentina Somatostatin for Injection Market Size, 2020-2032
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Somatostatin for Injection Revenue, 2020-2032
6.8.2 By Country - Middle East & Africa Somatostatin for Injection Sales, 2020-2032
6.8.3 Turkey Somatostatin for Injection Market Size, 2020-2032
6.8.4 Israel Somatostatin for Injection Market Size, 2020-2032
6.8.5 Saudi Arabia Somatostatin for Injection Market Size, 2020-2032
6.8.6 UAE Somatostatin for Injection Market Size, 2020-2032
7 Manufacturers & Brands Profiles
7.1 Biocon
7.1.1 Biocon Company Summary
7.1.2 Biocon Business Overview
7.1.3 Biocon Somatostatin for Injection Major Product Offerings
7.1.4 Biocon Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.1.5 Biocon Key News & Latest Developments
7.2 Ferring Pharmaceuticals
7.2.1 Ferring Pharmaceuticals Company Summary
7.2.2 Ferring Pharmaceuticals Business Overview
7.2.3 Ferring Pharmaceuticals Somatostatin for Injection Major Product Offerings
7.2.4 Ferring Pharmaceuticals Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.2.5 Ferring Pharmaceuticals Key News & Latest Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Somatostatin for Injection Major Product Offerings
7.3.4 Serum Institute of India Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.3.5 Serum Institute of India Key News & Latest Developments
7.4 UCB India Private Limited
7.4.1 UCB India Private Limited Company Summary
7.4.2 UCB India Private Limited Business Overview
7.4.3 UCB India Private Limited Somatostatin for Injection Major Product Offerings
7.4.4 UCB India Private Limited Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.4.5 UCB India Private Limited Key News & Latest Developments
7.5 Eumedica
7.5.1 Eumedica Company Summary
7.5.2 Eumedica Business Overview
7.5.3 Eumedica Somatostatin for Injection Major Product Offerings
7.5.4 Eumedica Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.5.5 Eumedica Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Somatostatin for Injection Major Product Offerings
7.6.4 Merck Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.6.5 Merck Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Somatostatin for Injection Major Product Offerings
7.7.4 Sanofi Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.7.5 Sanofi Key News & Latest Developments
7.8 PolyPeptide Group
7.8.1 PolyPeptide Group Company Summary
7.8.2 PolyPeptide Group Business Overview
7.8.3 PolyPeptide Group Somatostatin for Injection Major Product Offerings
7.8.4 PolyPeptide Group Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.8.5 PolyPeptide Group Key News & Latest Developments
7.9 Samarth Life Sciences Pvt
7.9.1 Samarth Life Sciences Pvt Company Summary
7.9.2 Samarth Life Sciences Pvt Business Overview
7.9.3 Samarth Life Sciences Pvt Somatostatin for Injection Major Product Offerings
7.9.4 Samarth Life Sciences Pvt Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.9.5 Samarth Life Sciences Pvt Key News & Latest Developments
7.10 Hybio Pharmaceutical
7.10.1 Hybio Pharmaceutical Company Summary
7.10.2 Hybio Pharmaceutical Business Overview
7.10.3 Hybio Pharmaceutical Somatostatin for Injection Major Product Offerings
7.10.4 Hybio Pharmaceutical Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.10.5 Hybio Pharmaceutical Key News & Latest Developments
7.11 Yangtze River Pharmaceutical
7.11.1 Yangtze River Pharmaceutical Company Summary
7.11.2 Yangtze River Pharmaceutical Business Overview
7.11.3 Yangtze River Pharmaceutical Somatostatin for Injection Major Product Offerings
7.11.4 Yangtze River Pharmaceutical Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.11.5 Yangtze River Pharmaceutical Key News & Latest Developments
7.12 Hainan Shuangcheng Pharmaceuticals
7.12.1 Hainan Shuangcheng Pharmaceuticals Company Summary
7.12.2 Hainan Shuangcheng Pharmaceuticals Business Overview
7.12.3 Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Major Product Offerings
7.12.4 Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.12.5 Hainan Shuangcheng Pharmaceuticals Key News & Latest Developments
7.13 Hainan Zhonghe Pharmaceutical
7.13.1 Hainan Zhonghe Pharmaceutical Company Summary
7.13.2 Hainan Zhonghe Pharmaceutical Business Overview
7.13.3 Hainan Zhonghe Pharmaceutical Somatostatin for Injection Major Product Offerings
7.13.4 Hainan Zhonghe Pharmaceutical Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.13.5 Hainan Zhonghe Pharmaceutical Key News & Latest Developments
7.14 Wuhan Hualong
7.14.1 Wuhan Hualong Company Summary
7.14.2 Wuhan Hualong Business Overview
7.14.3 Wuhan Hualong Somatostatin for Injection Major Product Offerings
7.14.4 Wuhan Hualong Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.14.5 Wuhan Hualong Key News & Latest Developments
7.15 Qingdao Guoda
7.15.1 Qingdao Guoda Company Summary
7.15.2 Qingdao Guoda Business Overview
7.15.3 Qingdao Guoda Somatostatin for Injection Major Product Offerings
7.15.4 Qingdao Guoda Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.15.5 Qingdao Guoda Key News & Latest Developments
7.16 Chengdu Shengnuo
7.16.1 Chengdu Shengnuo Company Summary
7.16.2 Chengdu Shengnuo Business Overview
7.16.3 Chengdu Shengnuo Somatostatin for Injection Major Product Offerings
7.16.4 Chengdu Shengnuo Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.16.5 Chengdu Shengnuo Key News & Latest Developments
7.17 Kumming Longjin Pharmaceutical
7.17.1 Kumming Longjin Pharmaceutical Company Summary
7.17.2 Kumming Longjin Pharmaceutical Business Overview
7.17.3 Kumming Longjin Pharmaceutical Somatostatin for Injection Major Product Offerings
7.17.4 Kumming Longjin Pharmaceutical Somatostatin for Injection Sales and Revenue in Global (2020-2025)
7.17.5 Kumming Longjin Pharmaceutical Key News & Latest Developments
8 Global Somatostatin for Injection Production Capacity, Analysis
8.1 Global Somatostatin for Injection Production Capacity, 2020-2032
8.2 Somatostatin for Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Somatostatin for Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Somatostatin for Injection Supply Chain Analysis
10.1 Somatostatin for Injection Industry Value Chain
10.2 Somatostatin for Injection Upstream Market
10.3 Somatostatin for Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Somatostatin for Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Somatostatin for Injection in Global Market
Table 2. Top Somatostatin for Injection Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Somatostatin for Injection Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Somatostatin for Injection Revenue Share by Companies, 2020-2025
Table 5. Global Somatostatin for Injection Sales by Companies, (K Units), 2020-2025
Table 6. Global Somatostatin for Injection Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Somatostatin for Injection Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Somatostatin for Injection Product Type
Table 9. List of Global Tier 1 Somatostatin for Injection Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Somatostatin for Injection Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type � Global Somatostatin for Injection Revenue, (US$, Mn), 2024 & 2032
Table 12. Segment by Type - Global Somatostatin for Injection Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Somatostatin for Injection Revenue (US$, Mn), 2026-2032
Table 14. Segment by Type - Global Somatostatin for Injection Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Somatostatin for Injection Sales (K Units), 2026-2032
Table 16. Segment by Application � Global Somatostatin for Injection Revenue, (US$, Mn), 2024 & 2032
Table 17. Segment by Application - Global Somatostatin for Injection Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Somatostatin for Injection Revenue, (US$, Mn), 2026-2032
Table 19. Segment by Application - Global Somatostatin for Injection Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Somatostatin for Injection Sales, (K Units), 2026-2032
Table 21. By Region � Global Somatostatin for Injection Revenue, (US$, Mn), 2025-2032
Table 22. By Region - Global Somatostatin for Injection Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Somatostatin for Injection Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Global Somatostatin for Injection Sales, (K Units), 2020-2025
Table 25. By Region - Global Somatostatin for Injection Sales, (K Units), 2026-2032
Table 26. By Country - North America Somatostatin for Injection Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Somatostatin for Injection Revenue, (US$, Mn), 2026-2032
Table 28. By Country - North America Somatostatin for Injection Sales, (K Units), 2020-2025
Table 29. By Country - North America Somatostatin for Injection Sales, (K Units), 2026-2032
Table 30. By Country - Europe Somatostatin for Injection Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Somatostatin for Injection Revenue, (US$, Mn), 2026-2032
Table 32. By Country - Europe Somatostatin for Injection Sales, (K Units), 2020-2025
Table 33. By Country - Europe Somatostatin for Injection Sales, (K Units), 2026-2032
Table 34. By Region - Asia Somatostatin for Injection Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Somatostatin for Injection Revenue, (US$, Mn), 2026-2032
Table 36. By Region - Asia Somatostatin for Injection Sales, (K Units), 2020-2025
Table 37. By Region - Asia Somatostatin for Injection Sales, (K Units), 2026-2032
Table 38. By Country - South America Somatostatin for Injection Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Somatostatin for Injection Revenue, (US$, Mn), 2026-2032
Table 40. By Country - South America Somatostatin for Injection Sales, (K Units), 2020-2025
Table 41. By Country - South America Somatostatin for Injection Sales, (K Units), 2026-2032
Table 42. By Country - Middle East & Africa Somatostatin for Injection Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Somatostatin for Injection Revenue, (US$, Mn), 2026-2032
Table 44. By Country - Middle East & Africa Somatostatin for Injection Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Somatostatin for Injection Sales, (K Units), 2026-2032
Table 46. Biocon Company Summary
Table 47. Biocon Somatostatin for Injection Product Offerings
Table 48. Biocon Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Biocon Key News & Latest Developments
Table 50. Ferring Pharmaceuticals Company Summary
Table 51. Ferring Pharmaceuticals Somatostatin for Injection Product Offerings
Table 52. Ferring Pharmaceuticals Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Ferring Pharmaceuticals Key News & Latest Developments
Table 54. Serum Institute of India Company Summary
Table 55. Serum Institute of India Somatostatin for Injection Product Offerings
Table 56. Serum Institute of India Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Serum Institute of India Key News & Latest Developments
Table 58. UCB India Private Limited Company Summary
Table 59. UCB India Private Limited Somatostatin for Injection Product Offerings
Table 60. UCB India Private Limited Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. UCB India Private Limited Key News & Latest Developments
Table 62. Eumedica Company Summary
Table 63. Eumedica Somatostatin for Injection Product Offerings
Table 64. Eumedica Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Eumedica Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Somatostatin for Injection Product Offerings
Table 68. Merck Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Merck Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Somatostatin for Injection Product Offerings
Table 72. Sanofi Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Sanofi Key News & Latest Developments
Table 74. PolyPeptide Group Company Summary
Table 75. PolyPeptide Group Somatostatin for Injection Product Offerings
Table 76. PolyPeptide Group Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. PolyPeptide Group Key News & Latest Developments
Table 78. Samarth Life Sciences Pvt Company Summary
Table 79. Samarth Life Sciences Pvt Somatostatin for Injection Product Offerings
Table 80. Samarth Life Sciences Pvt Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. Samarth Life Sciences Pvt Key News & Latest Developments
Table 82. Hybio Pharmaceutical Company Summary
Table 83. Hybio Pharmaceutical Somatostatin for Injection Product Offerings
Table 84. Hybio Pharmaceutical Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Hybio Pharmaceutical Key News & Latest Developments
Table 86. Yangtze River Pharmaceutical Company Summary
Table 87. Yangtze River Pharmaceutical Somatostatin for Injection Product Offerings
Table 88. Yangtze River Pharmaceutical Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Yangtze River Pharmaceutical Key News & Latest Developments
Table 90. Hainan Shuangcheng Pharmaceuticals Company Summary
Table 91. Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Product Offerings
Table 92. Hainan Shuangcheng Pharmaceuticals Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Hainan Shuangcheng Pharmaceuticals Key News & Latest Developments
Table 94. Hainan Zhonghe Pharmaceutical Company Summary
Table 95. Hainan Zhonghe Pharmaceutical Somatostatin for Injection Product Offerings
Table 96. Hainan Zhonghe Pharmaceutical Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. Hainan Zhonghe Pharmaceutical Key News & Latest Developments
Table 98. Wuhan Hualong Company Summary
Table 99. Wuhan Hualong Somatostatin for Injection Product Offerings
Table 100. Wuhan Hualong Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Wuhan Hualong Key News & Latest Developments
Table 102. Qingdao Guoda Company Summary
Table 103. Qingdao Guoda Somatostatin for Injection Product Offerings
Table 104. Qingdao Guoda Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Qingdao Guoda Key News & Latest Developments
Table 106. Chengdu Shengnuo Company Summary
Table 107. Chengdu Shengnuo Somatostatin for Injection Product Offerings
Table 108. Chengdu Shengnuo Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. Chengdu Shengnuo Key News & Latest Developments
Table 110. Kumming Longjin Pharmaceutical Company Summary
Table 111. Kumming Longjin Pharmaceutical Somatostatin for Injection Product Offerings
Table 112. Kumming Longjin Pharmaceutical Somatostatin for Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 113. Kumming Longjin Pharmaceutical Key News & Latest Developments
Table 114. Somatostatin for Injection Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 115. Global Somatostatin for Injection Capacity Market Share of Key Manufacturers, 2023-2025
Table 116. Global Somatostatin for Injection Production by Region, 2020-2025 (K Units)
Table 117. Global Somatostatin for Injection Production by Region, 2026-2032 (K Units)
Table 118. Somatostatin for Injection Market Opportunities & Trends in Global Market
Table 119. Somatostatin for Injection Market Drivers in Global Market
Table 120. Somatostatin for Injection Market Restraints in Global Market
Table 121. Somatostatin for Injection Raw Materials
Table 122. Somatostatin for Injection Raw Materials Suppliers in Global Market
Table 123. Typical Somatostatin for Injection Downstream
Table 124. Somatostatin for Injection Downstream Clients in Global Market
Table 125. Somatostatin for Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Somatostatin for Injection Product Picture
Figure 2. Somatostatin for Injection Segment by Type in 2024
Figure 3. Somatostatin for Injection Segment by Application in 2024
Figure 4. Global Somatostatin for Injection Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Somatostatin for Injection Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global Somatostatin for Injection Revenue: 2020-2032 (US$, Mn)
Figure 8. Somatostatin for Injection Sales in Global Market: 2020-2032 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Somatostatin for Injection Revenue in 2024
Figure 10. Segment by Type � Global Somatostatin for Injection Revenue, (US$, Mn), 2024 & 2032
Figure 11. Segment by Type - Global Somatostatin for Injection Revenue Market Share, 2020-2032
Figure 12. Segment by Type - Global Somatostatin for Injection Sales Market Share, 2020-2032
Figure 13. Segment by Type - Global Somatostatin for Injection Price (US$/Unit), 2020-2032
Figure 14. Segment by Application � Global Somatostatin for Injection Revenue, (US$, Mn), 2024 & 2032
Figure 15. Segment by Application - Global Somatostatin for Injection Revenue Market Share, 2020-2032
Figure 16. Segment by Application - Global Somatostatin for Injection Sales Market Share, 2020-2032
Figure 17. Segment by Application -Global Somatostatin for Injection Price (US$/Unit), 2020-2032
Figure 18. By Region � Global Somatostatin for Injection Revenue, (US$, Mn), 2025 & 2032
Figure 19. By Region - Global Somatostatin for Injection Revenue Market Share, 2020 VS 2024 VS 2032
Figure 20. By Region - Global Somatostatin for Injection Revenue Market Share, 2020-2032
Figure 21. By Region - Global Somatostatin for Injection Sales Market Share, 2020-2032
Figure 22. By Country - North America Somatostatin for Injection Revenue Market Share, 2020-2032
Figure 23. By Country - North America Somatostatin for Injection Sales Market Share, 2020-2032
Figure 24. United States Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 25. Canada Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 26. Mexico Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 27. By Country - Europe Somatostatin for Injection Revenue Market Share, 2020-2032
Figure 28. By Country - Europe Somatostatin for Injection Sales Market Share, 2020-2032
Figure 29. Germany Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 30. France Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 31. U.K. Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 32. Italy Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 33. Russia Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 34. Nordic Countries Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 35. Benelux Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 36. By Region - Asia Somatostatin for Injection Revenue Market Share, 2020-2032
Figure 37. By Region - Asia Somatostatin for Injection Sales Market Share, 2020-2032
Figure 38. China Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 39. Japan Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 40. South Korea Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 41. Southeast Asia Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 42. India Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 43. By Country - South America Somatostatin for Injection Revenue Market Share, 2020-2032
Figure 44. By Country - South America Somatostatin for Injection Sales, Market Share, 2020-2032
Figure 45. Brazil Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 46. Argentina Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 47. By Country - Middle East & Africa Somatostatin for Injection Revenue, Market Share, 2020-2032
Figure 48. By Country - Middle East & Africa Somatostatin for Injection Sales, Market Share, 2020-2032
Figure 49. Turkey Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 50. Israel Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 51. Saudi Arabia Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 52. UAE Somatostatin for Injection Revenue, (US$, Mn), 2020-2032
Figure 53. Global Somatostatin for Injection Production Capacity (K Units), 2020-2032
Figure 54. The Percentage of Production Somatostatin for Injection by Region, 2024 VS 2032
Figure 55. Somatostatin for Injection Industry Value Chain
Figure 56. Marketing Channels
